Abstract:Xiaoxi Deng, 1, &ast Xiaofei Guo, 1, &ast Xiaojie Chen, 2 Xinyu Zeng, 1 Jiamin Guo, 1 Xin Bai, 1 Ping Zhang, 1 Yuan Wang 1 1 Department of Pathology, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, 100102, People's Republic of China; 2 Department of Emergency, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, 100102, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yuan Wang, Ping Zhang, Department of Pathology, Wangjing Hospital, China Academy of Chinese Medical Sciences, 6 Wangjing Zhonghuan South Road, Chaoyang District, Beijing, 100102, People's Republic of China, Tel +86 010-84739040, Email ; Background: Acute myocardial infarction (AMI) is a severe acute coronary syndrome, demonstrating a trend toward affecting younger individuals in recent years. The association between early-onset myocardial infarction and single nucleotide polymorphism necessitates further exploration and evaluation. Case description: We present a case of a patient experiencing early-onset and recurrent myocardial infarction. The patient underwent stent implantation for myocardial infarction at the age of 53 and subsequently encountered two more myocardial infarctions within a span of 16 years. Following interventional therapy, genetic testing was conducted to assess the efficacy of subsequent anti-heart failure medications, with the aim to preemptively address heart failure risks. Genetic testing revealed a mutation in the angiotensin-converting enzyme (ACE) gene (rs577350502, g.63488533C>A), characterized by an intron-deletion single nucleotide variant. Conclusion: While this variant has not been previously reported to be associated with any specific disease, we hypothesize that it may contribute to the susceptibility and risk of myocardial infarction and coronary heart disease in the patient under consideration. This observation underscores the significance of investigating the insertion/deletion polymorphisms of the ACE gene in the context of AMI and emphasizes the necessity for further validation of this variant and other genetic markers associated with AMI in related diseases. Keywords: ACE, case reports, gene mutations, myocardial infarction, SNV Acute myocardial infarction (AMI) is a serious complication of coronary heart disease (CHD) primarily arising from severe stenosis or occlusion of coronary arteries, resulting in ischemic necrosis of the corresponding myocardial supply region. It represents a critical pathophysiological consequence within the spectrum of CHD. However, not all patients with CHD experience an AMI, and there might be some certain gene polymorphisms that contribute to the progression of coronary artery disease (CAD) into AMI. 1 Consequently, single nucleotide polymorphisms (SNPs) linked to AMI episodes warrant careful consideration. Early-onset AMI is defined by its occurrence in males under the age of 55 and females under the age of 60. 2 In this report, we present a case of a patient with early-onset and recurrent myocardial infarction, experiencing the initial episode at 53 years of age and subsequently enduring two more attacks over the next 16 years. Blood leukocyte DNA testing was conducted utilizing polymerase chain reaction (PCR) and Sanger sequencing, adhering to the ethical principles outlined in the Declaration of Helsinki. A 69-year-old male was transported to our hospital by ambulance following a heart attack, presenting with symptoms such as chest tightness, breathlessness, and vomiting of stomach contents. An emergency electrocardiogram (ECG) conducted en route revealed sinus rhythm with ST elevation in leads II, III, and AVF. Subsequent coronary angiography revealed coronary atherosclerotic heart disease, manifesting as double-vessel disease affecting the anterior descending artery and the right coronary artery (see Figure 1). The patient's blood test is shown in detail in Table 1. As per established diagnostic criteria, 3 the patient was diagnosed with acute inferior myocardial infarction. Emergency intervention was conducted, involving stent implantation for the right posterior descending coronary artery and the right posterior lateral coronary artery. Table 1 Blood Test Indexes of the Patient Figure 1 Coronary angiography. Remarkably, the patient's medical history revealed that this marked the third occurrence of such a procedure. The initial diagnosis of coronary atherosclerotic heart disease was made 16 years ago, leading to coronary stent implantation for myocardial infarction at the ages of 53 and 58, resulting in a total o -Abstract Truncated-

Mutations in Scap and Agxt2 Revealed by Exome Sequencing A Pedigree with Premature Myocardial Infarction

Digenic Mutations on SCAP and AGXT2 Predispose to Premature Myocardial Infarction

Exome Sequencing In A Family Identifies Recql5 Mutation Resulting In Early Myocardial Infarction

Using Exome Sequencing to Identify the Cause of Myocardial Hypertrophy in a Chinese Family.

Case report: A novel mutation of RecQ-like helicase 5 in a Chinese family with early myocardial infarction, coronary artery disease, and stroke hemiplegia

Identification of 11 Potentially Relevant Gene Mutations Involved in Growth Retardation, Intellectual Disability, Joint Contracture, and Hepatopathy

Next-generation Sequencing Identified Novel Desmoplakin Frame-Shift Variant in Patients with Arrhythmogenic Cardiomyopathy

Mutation screening of cardiac myosin binding protein-C3 gene in a Chinese pedigree with familial hypertrophic cardiomyopathy

Identification of a LMNA (c.646c > T) Variant by Whole-Exome Sequencing in Combination with a Dilated Cardiomyopathy (DCM) Related Gene Filter in a Family with Familiar DCM

Young and Early‐onset Dilated Cardiomyopathy with Malignant Ventricular Arrhythmia and Sudden Cardiac Death Induced by the Heterozygous LDB3, MYH6, and SYNE1 Missense Mutations

Mutation screening of MYH7 gene in a chinese pedigree with familial hypertrophic cardiomyopathy

Characterization of a novel SCN5A mutation associated with long QT syndrome and arrhythmogenic right ventricular cardiomyopathy in a family

The Cumulative Effects of the MYH7-V878A and CACNA1C-A1594V Mutations in a Chinese Family with Hypertrophic Cardiomyopathy

Novel compound heterozygous variants in EMC1: Overlapping phenotypes of left ventricular noncompaction and long QT syndrome warranting in‐depth exploration

Exome Sequencing Identifies a Novel MYH7 P.g407c Mutation Responsible for Familial Hypertrophic Cardiomyopathy

ACE Gene Mutations (rs577350502) in Early-Onset and Recurrent Myocardial Infarction: A Case Report and Review

Identification of a Novel Missense Mutation in the Cardiacβ-myosin Heavy Chain Gene in a Chinese Patient with Sporadic Hypertrophic Cardiomyopathy

Whole Exome Sequencing with a Focus on Cardiac Disease-Associated Genes in Families of Sudden Unexplained Deaths in Yunnan, Southwest of China

Identification of genetic mutation in a Chinese pedigree with congenital cataract by whole-exome sequencing

Whole-exome sequencing to identify causative variants in juvenile sudden cardiac death

Whole-exome sequencing identifies rare compound heterozygous mutations in the MYBPC3 gene associated with severe familial hypertrophic cardiomyopathy.